SISI, MONIA

SISI, MONIA  

Mostra records
Risultati 1 - 9 di 9 (tempo di esecuzione: 0.016 secondi).
Titolo Autore(i) Anno Periodico Editore Tipo File
Beyond EGFR, ALK and ROS1: Current evidence and future perspectives on newly targetable oncogenic drivers in lung adenocarcinoma Lamberti G.; Andrini E.; Sisi M.; Rizzo A.; Parisi C.; Di Federico A.; Gelsomino F.; Ardizzoni A. 2020-01-01 CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY - 1.01 Articolo in rivista -
Capmatinib-Induced Liver Injury as Emerging Toxicity of MET Inhibitors in Patients With NSCLC Pretreated With Immune Checkpoint Inhibitors Sisi, Monia; Vitale, Giovanni; Fusaroli, Michele; Riefolo, Mattia; Giunchi, Valentina; D’Errico, ...Antonietta; Ardizzoni, Andrea; Raschi, Emanuel; Gelsomino, Francesco 2023-01-01 JTO CLINICAL AND RESEARCH REPORTS - 1.01 Articolo in rivista -
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible? Di Federico A.; Nuvola G.; Sisi M.; Lenzi B.; Nobili E.; Campana D. 2020-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista -
Immune checkpoint inhibitors in lung tumors with rare histologies and other thoracic malignancies Andrini E.; Di Federico A.; Sisi M.; Rosellini M.; Palladini A.; Lamberti G.; De Giglio A.; Gelso...mino F. 2022-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
PD-L1 ≥ 50% lung cancer refractory to PD-1 inhibition: The role of salvage chemo-immunotherapy combination Gelsomino F.; Facchinetti F.; Sisi M.; Zielli T.; Tiseo M.; Ardizzoni A. 2021-01-01 IMMUNOTHERAPY - 1.01 Articolo in rivista -
Psychiatric Adverse Reactions to Anaplastic Lymphoma Kinase Inhibitors in Non-Small-Cell Lung Cancer: Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System Sisi, Monia; Fusaroli, Michele; De Giglio, Andrea; Facchinetti, Francesco; Ardizzoni, Andrea; Ras...chi, Emanuel; Gelsomino, Francesco 2022-01-01 TARGETED ONCOLOGY - 1.01 Articolo in rivista Sisi2022_Article_PsychiatricAdverseReactionsToA.pdf11523_2021_865_MOESM1_ESM.pdf
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution Di Federico A.; Andrini E.; Sisi M.; Nuvola G.; Lamberti G.; Lenzi B.; Nobili E.; Gelsomino F.; A...rdizzoni A. 2021-01-01 ANTI-CANCER DRUGS - 1.01 Articolo in rivista acd-32-755.pdf
Targeting DNA damage response and repair genes to enhance anticancer immunotherapy: Rationale and clinical implication Lamberti G.; Andrini E.; Sisi M.; Di Federico A.; Ricciuti B. 2020-01-01 FUTURE ONCOLOGY - 1.01 Articolo in rivista -
The mechanisms of PD-L1 regulation in non-small-cell lung cancer (NSCLC): Which are the involved players? Lamberti G.; Sisi M.; Andrini E.; Palladini A.; Giunchi F.; Lollini P.-L.; Ardizzoni A.; Gelsomin...o F. 2020-01-01 CANCERS - 1.01 Articolo in rivista Lamberti_PDL1_cancers-12-03129.pdf